Amy McGrath US Inactive
AMY MCGRATH FOR SENATE, INC.
⚠ Creative removed by Meta
This ad's image was taken down for violating Meta's ad standards; the copy below is preserved from the Ad Library.
This ad's image was taken down for violating Meta's ad standards; the copy below is preserved from the Ad Library.
Mitch is Failing Us
During this crisis, Mitch put drug companies first.
Ad copy
During a pandemic, Mitch put drug companies’ profits over the people he serves. We deserve better.
↗ View in Meta Ad Library (the live creative — image/video/layout)
Performance proxies
| Overall score | 56.9/100 |
| Spend / Reach / Long. / Eff. | 52.4 · 100.0 · 4.4 · 70.9 |
| Spend range | USD 6,000–6,999 |
| Impressions | 1,000,000 – 0 |
| CPM (≈ $/1k impr) | USD 6.5 |
| Est. audience size | 500,001 – 1,000,000 |
| Days live | 17 (2020-04-07 → 2020-04-24) |
| Created | 2020-04-07 |
| Creative variants | 1 body · 1 headline |
| Platforms | facebook, instagram |
| Languages | en |
| Candidate | KY — Amy Mcgrath |
| Surfaced by | “senate:Amy Mcgrath” |
🧠 AI analysis
| Issue | healthcare |
| Framing | attack opponent |
| Message type | persuasion |
| Emotional appeal | anger |
| Production tier | unknown |
| Who pictured | none |
| Symbols | none |
| Call to action | none |
| Standout element | Facebook content removal notice obscuring the actual ad creative |
| Tactic | The ad attacks McConnell for prioritizing pharmaceutical profits over constituents during the pandemic, leveraging urgency and anger with the tagline 'Mitch is Failing Us,' though the actual creative is inaccessible due to a policy disclaimer violation takedown. |
Where it ran (delivery by region)
| Kentucky | 100.0% |
Who saw it (delivery)
| 65+ · unknown | 0.0% |
| 45-54 · unknown | 0.1% |
| 35-44 · unknown | 0.1% |
| 65+ · male | 1.4% |
| 25-34 · unknown | 0.1% |
| 18-24 · unknown | 0.1% |
| 55-64 · male | 2.8% |
| 65+ · female | 4.6% |
| 18-24 · male | 5.1% |
| 35-44 · female | 15.5% |
| 35-44 · male | 6.3% |
| 55-64 · female | 8.4% |
| 45-54 · male | 4.5% |
| 25-34 · female | 19.3% |
| 45-54 · female | 11.5% |
| 18-24 · female | 10.7% |
| 25-34 · male | 9.4% |
| 55-64 · unknown | 0.0% |
